The most consequential misread in lip augmentation is not exotic. It is the decision, made in about four seconds by an experienced clinician looking at a discoloured upper lip, that the answer to bruise or vascular occlusion is bruise. That decision is usually correct. It is also the decision that produces the cases that end in surgical reconstruction, because when it is wrong, nothing about the next twelve hours corrects it. The patient goes home reassured, the injector goes on to the next appointment, and the only thing still happening is ischemia.
This piece is written as a differential for the injector, not as reassurance for the patient. If you want the patient-facing companion — the piece to send someone who has just noticed something on their lip and is looking for an explanation of normal post-treatment change — that is common lip filler reactions and how to avoid them. What follows is the clinical reasoning that sits underneath it.
Why "bruise" wins the argument it should not win
Ecchymosis after lip filler is genuinely common. Systematic reviews of hyaluronic acid lip augmentation consistently report local injection-site reactions — swelling, contusion, bruising, pain, erythema — as the dominant adverse events across thousands of treated subjects (Stojanović and Majdič, J Cosmet Dermatol 2019;18:436-443; Colon et al., Cureus 2023;15:e38286). The vermilion is thin, mobile, densely vascular and repeatedly punctured. Bruising is the expected outcome, not the exception.
That base rate is exactly the problem. When a clinician sees discolouration on a lip they have just injected, the diagnosis that arrives first is the one that is almost always true. It arrives fast, it arrives without effort, and it arrives carrying the patient's agreement — because patients supply it themselves. Michelle Langston puts the sentence in the patient's mouth because that is where she has heard it: "Oh, it's just a bruise. I bruise a lot."
Two clinicians now hold the same working diagnosis, one of whom has a financial and emotional interest in it being correct, and neither of whom has yet performed a perfusion assessment. That is not a knowledge failure. Every injector reading this can list the signs of occlusion. It is a failure of the assessment ever being started.
The two processes are not the same injury
Before the physical findings, fix the mechanism, because the findings fall out of it.
An ecchymosis is blood outside the vessel. A needle or cannula lacerates a vessel wall, blood escapes into the interstitium, and haemoglobin sits in tissue where it is slowly broken down. The discolouration is extravascular pigment. The tissue around it is perfused normally. Nothing is ischemic. The process is complete at the moment the bleeding stops, and everything after that is resorption.
A vascular occlusion is product inside the vessel. Hyaluronic acid enters the lumen and either plugs it proximally or disperses distally, and the tissue downstream loses its arterial supply. The discolouration is not pigment in the tissue — it is a haemodynamic phenomenon, deoxygenated blood accumulating in post-capillary venules behind an arterial blockade, which is the mechanism underlying the livedoid pattern described in the filler-induced vascular occlusion literature (Soares, Molecules 2022;27:5398). The process is not complete. It is ongoing, and it progresses through defined stages over days if nothing interrupts it (Murray et al., J Clin Aesthet Dermatol 2021;14:E61-E69).
One is a finished event being cleaned up. The other is a live event getting worse. Every discriminating sign below is a way of asking which of those two you are looking at.
The discriminating findings
None of these is individually diagnostic. Used together, and used deliberately rather than glanced at, they separate the two processes most of the time.
Distribution relative to what you treated. Ecchymosis is a puncture phenomenon. It sits at or immediately around the entry points, it is often multifocal and irregular, and it will track with gravity and tissue planes over the following day — which is why lip bruising so often ends up in the cutaneous lip or the chin rather than where the needle went. Ischemic change is a territory phenomenon. Its shape is dictated by an arterial tree, not by where you punctured, and it will occupy a segment of perfused tissue with a boundary that makes vascular sense. In Langston's case the involvement crossed the entire upper lip and left the lower lip untouched, which is not how a scatter of needle-track bruises behaves.
Sparing of adjacent tissue you also traumatised. This is the single most useful discriminator in the lips and it is nearly free. If you treated only the upper lip and the upper lip is involved while the lower lip is clean, you have an internal control. Both regions would have been equally exposed to a generalised insult — none was applied to the lower lip, and the lower lip is fine. That pattern argues for a perfusion problem confined to one supply territory rather than diffuse trauma or a generalised reaction. Langston reasons through exactly this in her case: there is no bottom lip involvement, because I did not inject in that area in that same injection pattern.
Response to gentle pressure. Extravasated blood does not blanch. Press on an established ecchymosis and the colour stays, because the pigment is in the tissue, not in a vessel you can empty. The violaceous, mottled pattern of early ischemia is intravascular; it will usually blanch under pressure and then refill, and the refill is the finding — slow, sluggish, obviously different from the untreated side. Use this as a supporting sign and not as a rule-out. The two processes coexist constantly, since the same pass that entered a vessel probably also lacerated one, and a non-blanching patch inside a territorial distribution excludes nothing at all.
Capillary refill against the patient's own control tissue. Do not chase an absolute number on lip mucosa. Compare. Press the involved segment, press the equivalent point on the untreated lip or the contralateral side, and compare the two refills with your eyes on both. An asymmetric refill in a patient whose baseline is their own other lip is worth more than any threshold you could quote.
Temperature. Compare with the back of a gloved finger, involved side against uninvolved side. A bruise is not cool. Coolness is a perfusion finding and should move you decisively.
Pain quality and trajectory. Post-injection soreness is dull, expected and settling. The pain that matters is disproportionate to the procedure, and more importantly it is not settling — it is the same or worse twenty minutes later. In the FIVO literature, disproportionate pain and skin discolouration were reported in roughly 80% and 70% of ischemic cases respectively (Soares, Molecules 2022, summarising Soares et al., Plast Reconstr Surg 2023;151:592e-608e). Note what that also means: a meaningful minority of real occlusions were not painful. Pain that is present and wrong is a strong positive; pain that is absent is a weak negative. Langston's rule is the one to carry — pain and colour change means delayed refill, and it means stop.
Trajectory over the next twenty minutes. This is the most reliable discriminator you have and it costs you nothing but the chair. A bruise, observed over twenty minutes, does essentially nothing. It is a static finding. Early ischemia observed over twenty minutes extends — the boundary moves, the pattern becomes more reticular, the colour deepens. If you are uncertain, do not resolve the uncertainty by thinking harder. Resolve it by looking again at a known interval with the patient in front of you.
Colour evolution over days. This one only helps retrospectively, but it belongs in the mental model. Ecchymosis follows haemoglobin breakdown — red-purple, then blue, then green, then yellow-brown, and it fades. Ischemic skin follows a different sequence entirely: pallor with delayed refill, then livedoid mottling over the first seventy-two hours, then barrier failure and desquamation, then coagulative necrosis at roughly five to ten days (Murray et al., 2021). Nothing about the bruise sequence includes desquamation.
What the beautiful result is evidence of
Langston's case is a healthy adult who wanted upper lip definition, received hyaluronic acid in small aliquots, and left with a good result. The office got a phone call about fifteen minutes later.
The result being beautiful is the trap. It feels like evidence, and it is evidence — about aesthetics. It is not evidence about perfusion, and the two questions are entirely independent. A perfectly balanced, symmetric, well-proportioned lip can sit on top of an occluded superior labial branch, and it will look exactly as good in the photograph you were about to take. Langston says it directly: don't let that ego get in your way and say, oh, it's just a bruise.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
The same applies to knowing the patient. I have injected her before, I know this person is a statement about your relationship, not about her tissue. It should not enter the differential, and in practice it enters the differential more often than any textbook sign.
The decision rule, which is not a likelihood judgement
Here is where the reasoning has to stop being diagnostic and start being economic, because the diagnostic question is genuinely hard and the management question is genuinely easy.
You are not required to prove occlusion. You are required to exclude it or treat it. Those are the only two acceptable exits from the room.
Weigh the two errors honestly. If you treat an ecchymosis as an occlusion, you have dissolved product the patient paid for, you have an awkward conversation, and you will rebuild the lip at a later date. If you treat an occlusion as an ecchymosis, the tissue continues to die while both of you feel reassured, and the ceiling on the outcome drops every hour. Those costs are not remotely symmetric, which means the correct decision threshold is not fifty per cent. It is far, far lower.
Langston's version is three words long: if there's any question, you treat. Her sequence when something looks wrong is recognise, stop and reassess — stop injecting, do not finish the syringe, then assess capillary refill, pain, colour and coolness, then act on the protocol you have already rehearsed, then reassess and escalate. And the absolute: any visual symptom is an immediate stop, full stop, no deliberation. For why that particular rule has no exceptions, see can Botox cause blindness, which covers the ophthalmic consequences that make visual complaints categorically different from cutaneous ones.
The operational precondition is the one most practices fail on paper and pass in the moment they need it. Never inject hyaluronic acid filler without hyaluronidase available in the building, and never own a protocol your team has not rehearsed. A decision rule you cannot execute in the next ninety seconds is not a decision rule. Dissolving filler covers the agent itself; the point here is only that the answer to "is this a bruise" is allowed to be "I am going to act as though it is not."
These figures and techniques reflect Michelle Langston's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
What to change on Monday
Three concrete changes, all structural rather than intellectual.
Perform the perfusion check as a separate act. Not while admiring the result, not while the patient holds the mirror. Put the syringe down, change what you are looking at, and run the same four items every time: colour against the untreated side, refill against the untreated side, temperature, and what the patient reports about pain right now compared with five minutes ago. It takes about twenty seconds and it is the only part of the appointment that is looking for the thing that ruins lives.
Name your control tissue before you inject. Decide, out loud or in the chart, what you will be comparing against — the lower lip, the contralateral side, the untreated cutaneous lip. Doing this before treatment means the comparison exists as a habit rather than as an improvisation performed under adrenaline.
Change the question you ask yourself. "Does this look like a bruise?" is a confirmation question and it will find confirmation. The question that works is: if this were ischemia, what would I expect to see right now, and have I looked for it? That is a different cognitive operation, and it sends you to the lower lip, to the refill, and to the clock.
Empire's Complete Dermal Filler Training covers perioral filler technique with complication recognition built into the hands-on work rather than bolted on as a lecture, and Anatomical Based Aesthetics Training and Special Anatomical Cadaver Aesthetics Training address the labial and perioral vascular anatomy that makes the territorial reasoning above possible in the first place.
Frequently Asked Questions
Can a bruise and a vascular occlusion be present at the same time?
Yes, and it is common. The same pass that deposits product intravascularly may also lacerate a vessel. A visible ecchymosis therefore does not exclude an occlusion and should never be used as reassurance. When both are plausible, assess the findings that depend on perfusion — capillary refill, temperature, pain trajectory and distribution — rather than the colour itself.
Does blanching on pressure rule out ischemia in the lip?
No. Extravasated blood does not blanch and the intravascular congestion of early ischemia usually does, so the test can support a bruise. But the two coexist, blanching is inconsistent in real cases, and a non-blanching patch sitting inside a territorial distribution still demands a perfusion assessment. Treat it as one supporting sign among several, never as a rule-out.
How long should I observe before deciding?
Observe with the patient still in the chair and re-examine at a fixed short interval rather than sending them home to watch. Trajectory is the most useful discriminator: a bruise is static over twenty minutes, early ischemia extends. Observation is only defensible while you remain able to act immediately; it is not an alternative to acting.
What if the patient insists it is just a bruise?
The patient's reassurance is not clinical data, and patients supply it reliably because bruising is their prior experience. Tell them plainly that you are assessing blood supply rather than appearance, that the assessment takes a few minutes, and that you need them to stay. Document what they reported, what you found and what you advised.
Is the cosmetic result relevant to whether an occlusion happened?
No. Aesthetic quality and tissue perfusion are independent. A symmetric, well-proportioned lip can overlie an occluded vessel, and an unusually good result tends to increase rather than decrease the risk of a delayed diagnosis because it biases the clinician toward believing nothing has gone wrong.
Disclaimer
This article reflects the clinical opinions and experience of Michelle Langston, APRN, MSN, FNP-BC, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
